Boomsma M M, Stearns-Kurosawa D J, Stegeman C A, Raschi E, Meroni P L, Kurosawa S, Tervaert J W Cohen
Department of Internal Medicine, University Hospital Groningen, The Netherlands.
Clin Exp Immunol. 2002 Apr;128(1):187-94. doi: 10.1046/j.1365-2249.2002.01803.x.
Elevated soluble thrombomodulin (sTM) levels are an accepted marker of endothelial damage. The physiological significance of plasma endothelial protein C receptor (sEPCR) levels is not known. To assess the relevance of this plasma protein in Wegener's granulomatosis (WG), sEPCR levels were measured in sera obtained from WG patients and related to disease activity, sTM levels, and other known markers of disease activity. In total, 129 sera (37 at active disease, 92 during follow-up) from 31 WG patients were tested. During active disease, eight (22%) and 17 (46%) out of 37 active sera had elevated levels of sEPCR and sTM, respectively (NS); sEPCR (r = 0.39; P = 0.02) and sTM (r = 0.53; P <0.01) levels correlated with disease activity (Birmingham Vasculitis Activity Score). Analysis of longitudinal sera revealed a significant increase in sEPCR (P = 0.01) and sTM (P = 0.04) levels prior to the moment of a relapse. Corrected for renal function, the increase in sEPCR remained significant (P =0.04) whereas sTM did not (NS). Levels of sEPCR correlated with sTM levels (r = 0.32; P < 0.001). Plasma levels of sEPCR respond to changes in the disease in patients with WG.
可溶性血栓调节蛋白(sTM)水平升高是公认的内皮损伤标志物。血浆内皮蛋白C受体(sEPCR)水平的生理意义尚不清楚。为了评估这种血浆蛋白在韦格纳肉芽肿(WG)中的相关性,我们检测了WG患者血清中的sEPCR水平,并将其与疾病活动度、sTM水平及其他已知的疾病活动标志物进行关联分析。总共检测了31例WG患者的129份血清(疾病活动期37份,随访期92份)。在疾病活动期,37份活动期血清中有8份(22%)sEPCR水平升高,17份(46%)sTM水平升高(无显著性差异);sEPCR(r = 0.39;P = 0.02)和sTM(r = 0.53;P <0.01)水平与疾病活动度(伯明翰血管炎活动评分)相关。对纵向血清的分析显示,复发前sEPCR(P = 0.01)和sTM(P = 0.04)水平显著升高。校正肾功能后,sEPCR的升高仍具有显著性(P =0.04),而sTM则无显著性差异(无显著性差异)。sEPCR水平与sTM水平相关(r = 0.32;P < 0.001)。WG患者血浆sEPCR水平会随疾病变化而变化。